PMI Launches Make Reality Virtual Hub to Inspire People to Turn Ideas Into Reality
Project Management Institute (PMI) today launched Make Reality, a virtual hub designed to inspire and support changemakers as they drive transformation and create positive social impact across the world while navigating the COVID-19 pandemic. Telling the unique stories of changemakers – those at the forefront of driving change, personally and professionally – as they created impact in today’s project-centered world, the virtual hub empowers changemakers to get started on their next project or see a project through to the finish line that was left on hold.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210908005777/en/
Nearly four in five consumers (79 percent) in PMI’s Make Reality Global Survey 20201said they consider 2021 a “do-over” year due to the COVID crisis. But 83 percent said 2020 prepared them for 2021, and an even greater number (86 percent) plan to work harder this year to bring their good ideas to life.
“The pandemic disrupted countless 2020 plans, but many leaders and innovative thinkers used the time wisely to map out their next moves,” said PMI Chief Operating Office Mike DePrisco. “As more communities and organizations across the globe cautiously turn to recovery and revival, teams are increasingly focused on turning their stalled projects into reality. However, making that idea a reality isn’t easy and requires effective project skills and new ways of working; that’s why PMI is empowering changemakers to take action through the Make Reality virtual hub.”
From KICKOFF™ to Power Skills
The PMI virtual hub features videos and true stories of changemakers across the globe turning their ideas into reality – from creating biodegradable batteries for electric vehicles in India to restoring animal habitats following the Australian wildfires. The hub also connects changemakers to PMI tools, resources, and courses on project management best practices, including KICKOFF – a free, 45-minute digital course and toolkit that guides learners through the basics of project management with bite-sized content and downloadable templates they can quickly implement on the job.
The Make Reality virtual hub also helps project management professionals and non-professionals identify their unique changemaker persona and offers information about the “power skills” or social behaviors – like communications, empathy, collaborative leadership, and an innovative mindset – that are important in driving change and allow people to work well together to get things done. They complement the technical or vocational skills required and can often spell the difference between a project’s success or failure.
Research Offers Reasons for Optimism
The vast majority of changemakers are open to learning new skills. According to the PMI survey, 81 percent of consumers plan to learn new skills to bring their projects to life. Nearly three-quarters (73 percent) plan to take a more active role in driving change, and 66 percent are optimistic about their ability to be successful.
Consumers are bringing similar ambitions – and a certain adventurous spirit – to their professional lives. Over two in ten (22 percent) are interested in starting their own business, and a similar number (22 percent) want to start a new job. They are also interested in increasing their level of responsibility on the job (28 percent) and learning new, job-related skills (31 percent).
Among these are power skills like creativity (35 percent), communication (38 percent), and collaboration/teamwork (25 percent), as well as project management skills themselves (24 percent)2.
“We hope to build on this sense of excitement and optimism with our Make Reality virtual hub,” DePrisco said. “We believe there’s a pent-up desire to make change and to have impact in all spheres of peoples’ lives – personal, professional, and in the realm of social good. Our goal is to give people the tools – and a bit of inspiration – to get started.”
For inspiration and to take the next step into turning their idea into reality, changemakers can visit pmi.org/Make-Reality.
About Project Management Institute
Project Management Institute (PMI) is the world's leading professional association for a growing community of millions of project professionals and changemakers worldwide.
As the world’s leading authority on project management, PMI empowers people to make ideas a reality. Through global advocacy, networking, collaboration, research, and education, PMI prepares organizations and individuals to work smarter so they can drive success in a world of change.
Building on a proud legacy dating to 1969, PMI is a “for-purpose” organization working in nearly every country around the world to advance careers, strengthen organizational success, and enable changemakers with new skills and ways of working to maximize their impact. PMI offerings include globally recognized standards, certifications, online courses, thought leadership, tools, digital publications, and professional communities. Visit us at pmi.org and connect with us on LinkedIn, Facebook, Twitter, and Instagram to keep up with the latest from PMI.
Survey Methodology:
Project Management Institute fielded two online global surveys among 8750 total respondents between November 6 and November 25, 2020. A total number of 1750 business leaders who influence or make decisions on behalf of their company (250 per country) and 7000 general consumers (1000 per country) were surveyed from the following countries: United States, United Kingdom, Australia, India, Singapore, South Africa and the United Arab Emirates. Best efforts were made to balance the general consumer samples to reflect their respective national representation across gender, age, region, household income and race/ethnicity. The estimated margin of error (MOE) was 2.3% for the business thought leader survey and 1.7% for the general consumer survey at a 95% level of confidence.
_______________
1 Project Management Institute. (2020). Make Reality Global Survey.
2 Project Management Institute. (2020). Make Reality Global Survey.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210908005777/en/
Contact information
MaryKate Dougherty
Corporate Communications Specialist
MaryKate.Dougherty@pmi.org
Ileana Alamo
Latin America Media
Ileana.Alamo@pmi.org
Tariq Ahmed
Europe & Africa Media
Tariq.Ahmed@pmi.org
Celine Nehme
Middle East & North Africa Media
Celine.Nehme@pmi.org
Devika Puri
South Asia & Asia Pacific Media
Devika.Puri@pmi.org
Mary Yang
China Media
Mary.Yang@pmi.org
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press Release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
Incyte Japan Announces Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press Release
Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press Release
Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus
Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press Release
Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
